Chronic condition therapeutic developer Sweetch announced today that Dr. Robert A. Gabbay has joined the company as an advisor. Gabbay currently serves as the chief scientific and medical officer at the American Diabetes Association, leading the organization's efforts to drive discovery in diabetes research, care and prevention. He also serves as an associate professor of [...]The post Sweetch adds American Diabetes Association exec to its advisory board appeared first on Drug Delivery Business.
Sweetch is an Israel-based AI-powered platform that offers solutions such as personalized recommendations and digital therapeutics for the patients with chronic conditions.